The latest biotech news

News and Trends 13 Apr 2015

Humabs and MedImmune partnership to develop an Influenza A treatment

Medimmune starts phase I clinical trial to investigate an antibody developed under a collaboration with Humabs BioMed for the treatment of influenza A. The novel antibody developed through Humabs’ Cellclone technology…

April 13, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 11 Apr 2015

Cardio3 Biosciences Embedded BioLife Solutions for a Heart Regenerative Therapy

Cardio3 BioSciences is again on the front page of biotech news. After announcing the launching of an IPO on Nasdaq and getting an US patent, the company has now embedded the BioLife…

April 11, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 10 Apr 2015

FuturaGene’s Genetically Modified Eucalyptus approved in Brazil

The Brazilian National Technical Commission on Biosafety (CTNBio) approved the commercial use of the yield enhanced eucalyptus developed by FuturaGene, the leading Israeli agricultural biotech. Field experiments conducted since 2006…

April 10, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 9 Apr 2015

Ipsen and Hannover Medical School start joint research in Recombinant Botulinum Neurotoxins

Ipsen and Hannover Medical School, one of the world’s leading university medical centres, have entered into a joint research collaboration agreement, signed in last September. Their objective is to develop…

April 9, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 9 Apr 2015

Exclusive interview with Laurent Levy, CEO of Nanobiotix, Leading European Nanomedicine Biotech

Nanomedicine could be the next revolution in healthcare and Paris-based Nanobiotix is one of the leading biotech in the field. It started from a vision in 2003 and now counts 50…

April 9, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 8 Apr 2015

CRISPR Therapeutics opens Boston R&D Office to Win the CRISPR War

CRISPR Therapeutics appointed Bill Lundberg to Chief Scientific Officer to lead the company’s development programs and to spearhead the creation of its R&D operations in Cambridge, Massachusetts. The biopharmaceutical company…

April 8, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 8 Apr 2015

Cardio3, the leading Stem Cell Biotech gets a US patent on CAR-T

Just a week after announcing its intention to launch an IPO in the United States, Cardio3 Biosciences continues increasing its presence in the States. The company has received a Notice…

April 8, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 7 Apr 2015

A New Key Strategic Collaboration Between BMS and UniQure

Last month, Bristol-Myers Squibb (BMS) and UniQure, the Dutch pioneer in human gene therapy, were at the forefront of the scene after having agreed on two collaborations, respectively, an agreement between Bavarian Nordic…

April 7, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 7 Apr 2015

Open Bionics, lending a 3D-Printed helping hand

Little could the young Joel Gibbard have ever imagined that those Meccano games he once used to play with as a child, would one day lead him to become Britain’s…

April 7, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 6 Apr 2015

Gene editing to make French fries less unhealthy

A promising biotechnological approach or an innovative way of avoiding regulation? Large companies spend an average of €126M on the development of a genetically engineered crop (GMO), including €32M in…

April 6, 2015 - 4 minutesmins - By Cédric Brock

News and Trends 4 Apr 2015

An Exclusive Agreement Supporting Patients Requiring Access to an Intravenous Nutritional Therapy

April 4, 2015 - 0 minutesmins - By Julie Lellouche

News and Trends 3 Apr 2015

Back to Middle Age to re-discover some medicinal treatments

The long medieval period extends in the West over nearly a millennium and gradually enriched its knowledge in the medical field. Admired by the Greeks, Egyptian medicine made reference in…

April 3, 2015 - 4 minutesmins - By Cédric Brock

News and Trends 3 Apr 2015

The Strategic Focus of Roche-Genentech on Personal Genetic data

Personal Genetic data plays more and more a critical role in drug development. Major Pharma company Roche and its Biotech subsidiary Genentech are iconic in this trend. They have always been…

April 3, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 2 Apr 2015

Anergis completed Phase II for AllerT, a novel treatment for pollen allergies

Anergis announced treatment completion of its Phase II clinical trial of AllerT, a novel long-peptide immunotherapeutic to treat birch pollen allergies. Anergis’ approach uses synthetic, pharmaceutical-grade Contiguous Overlapping Peptide ("COP"),…

April 2, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 2 Apr 2015

Interview with CELLPROTHERA, the regenerative medicine pioneer

CellProthera is a medical biotech company founded in 2008 in Mulhouse, France. The young innovative company focuses on the use of blood peripheral stem cells. CellProthera is the origin of…

April 2, 2015 - 7 minutesmins - By Nicolas Sainte-Foie

News and Trends 1 Apr 2015

Cardio3 will launch an IPO in the United States

Cardio3 BioSciences, a leader in engineered cell therapies with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced its intention to conduct a registered public offering in…

April 1, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 31 Mar 2015

Merck Serono and Intrexon, to develop CAR-T Therapy

Merck Sereno, the biopharmaceutical business of Merck, and the synthetic biology leader Intrexon announced yesterday an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. …

March 31, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 30 Mar 2015

#BioFigures: €406 Million Antibody-drug conjugate Deal struck by ImmunoGen andTakeda

WHO? ImmunoGen is a biotechnology company that develops targeted anticancer therapeutics using its state-of-the-art antibody-drug conjugate (ADC) technology. The Company's uses tumor-targeting antibodies to deliver an ImmunoGen cell-killing agent specifically to…

March 30, 2015 - 3 minutesmins - By Marie Godar

News and Trends 28 Mar 2015

Strategic Partnership Between Green Cross and Nanolek

The South Korean biopharmaceutical company Green Cross and the Russian pharmaceutical company Nanolek signed a strategic partnership agreement for the commercialisation of Green Cross' biologics in the Russian market. Green Cross…

March 28, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 27 Mar 2015

OSE Pharma raised €21.1 Million

OSE Pharma’s Initial Public Offering couldn’t have been more successful as it just raised €21.1M. Noticing the strong demand for shares, the board of OSE Pharma has increased the price…

March 27, 2015 - 1 minutemin - By Lourdes Riquelme

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering